Energy Metabolism Disturbances in Cell Models of PARK2 CNV Carriers with ADHD

被引:6
|
作者
Palladino, Viola Stella [1 ]
Chiocchetti, Andreas G. [2 ]
Frank, Lukas [1 ]
Haslinger, Denise [2 ]
McNeill, Rhiannon [3 ]
Radtke, Franziska [4 ]
Till, Andreas [5 ,6 ]
Haupt, Simone [7 ,8 ]
Bruestle, Oliver [5 ,6 ]
Guenther, Katharina [9 ,10 ,11 ]
Edenhofer, Frank [9 ,10 ]
Hoffmann, Per [6 ,12 ]
Reif, Andreas [1 ]
Kittel-Schneider, Sarah [1 ,3 ]
机构
[1] Goethe Univ, Univ Hosp, Dept Psychiat Psychotherapy & Psychosomat Med, D-60528 Frankfurt, Germany
[2] Univ Hosp Frankfurt, Dept Child & Adolescent Psychiat & Psychotherapy, D-60528 Frankfurt, Germany
[3] Univ Wurzburg, Univ Hosp, Dept Psychiat Psychotherapy & Psychosomat Med, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Univ Hosp, Dept Child & Adolescent Psychiat Psychotherapy &, D-97080 Wurzburg, Germany
[5] Univ Bonn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, Med Fac, D-53127 Bonn, Germany
[6] Univ Hosp Bonn, D-53127 Bonn, Germany
[7] LIFE & BRAIN GmbH, Cell Unit, D-53127 Bonn, Germany
[8] Univ Cologne, Dept 75, Transfer, D-50923 Cologne, Germany
[9] Univ Innsbruck, Inst Mol Biol, AT-6020 Innsbruck, Austria
[10] Univ Innsbruck, CMBI, AT-6020 Innsbruck, Austria
[11] Paracelsus Med Univ Salzburg, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, AT-5020 Salzburg, Austria
[12] Univ Bonn, LIFE & BRAIN Ctr, Inst Humane Genet, Med Fac, D-53127 Bonn, Germany
基金
欧盟地平线“2020”;
关键词
ADHD; hiPSC; PARK2; mitochondria; disease modelling; DEFICIT-HYPERACTIVITY DISORDER; MITOCHONDRIAL DYSFUNCTION; PARKINSON DISEASE; REGULATORS; UBIQUITIN; STRESS; IMPACT; PINK1;
D O I
10.3390/jcm9124092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main goal of the present study was the identification of cellular phenotypes in attention-deficit-/hyperactivity disorder (ADHD) patient-derived cellular models from carriers of rare copy number variants (CNVs) in the PARK2 locus that have been previously associated with ADHD. Human-derived fibroblasts (HDF) were cultured and human-induced pluripotent stem cells (hiPSC) were reprogrammed and differentiated into dopaminergic neuronal cells (mDANs). A series of assays in baseline condition and in different stress paradigms (nutrient deprivation, carbonyl cyanide m-chlorophenyl hydrazine (CCCP)) focusing on mitochondrial function and energy metabolism (ATP production, basal oxygen consumption rates, reactive oxygen species (ROS) abundance) were performed and changes in mitochondrial network morphology evaluated. We found changes in PARK2 CNV deletion and duplication carriers with ADHD in PARK2 gene and protein expression, ATP production and basal oxygen consumption rates compared to healthy and ADHD wildtype control cell lines, partly differing between HDF and mDANs and to some extent enhanced in stress paradigms. The generation of ROS was not influenced by the genotype. Our preliminary work suggests an energy impairment in HDF and mDAN cells of PARK2 CNV deletion and duplication carriers with ADHD. The energy impairment could be associated with the role of PARK2 dysregulation in mitochondrial dynamics.
引用
收藏
页码:1 / 20
页数:20
相关论文
共 50 条
  • [1] Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
    Tijero, Beatriz
    Gabilondo, Inigo
    Lezcano, Elena
    Teran-Villagra, Nuria
    Llorens, Veronica
    Ruiz-Martinez, Javier
    Felix Marti-Masso, Jose
    Carmona, M.
    Rosario Luquin, Maria
    Berganzo, Koldo
    Fernandez, Ivan
    Fernandez, Manuel
    Jose Zarranz, Juan
    Carlos Gomez-Esteban, Juan
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (07) : 717 - 722
  • [2] Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease
    Huttenlocher, Johanna
    Stefansson, Hreinn
    Steinberg, Stacy
    Helgadottir, Hafdis T.
    Sveinbjornsdottir, Sigurlaug
    Riess, Olaf
    Bauer, Peter
    Stefansson, Kari
    HUMAN MOLECULAR GENETICS, 2015, 24 (19) : 5637 - 5643
  • [3] Cutaneous squamous cell carcinoma and the PARK2 gene
    Inzelberg, R.
    Friedman, E.
    Azizi, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (01) : 323 - 324
  • [4] The clinical spectrum of PARKIN disease (PARK2) and heterozygous gene mutation carriers
    Stark, R.
    Walch, J.
    Tettenborn, B.
    Kaegi, G.
    MOVEMENT DISORDERS, 2015, 30 : S472 - S473
  • [5] PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons
    Bogetofte, Helle
    Jensen, Pia
    Ryding, Matias
    Schmidt, Sissel, I
    Okarmus, Justyna
    Ritter, Louise
    Worm, Christina S.
    Hohnholt, Michaela C.
    Azevedo, Carla
    Roybon, Laurent
    Bak, Lasse K.
    Waagepetersen, Helle
    Ryan, Brent J.
    Wade-Martins, Richard
    Larsen, Martin R.
    Meyer, Morten
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [6] Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
    Okarmus, Justyna
    Havelund, Jesper F.
    Ryding, Matias
    Schmidt, Sissel, I
    Bogetofte, Helle
    Heon-Roberts, Rachel
    Wade-Martins, Richard
    Cowley, Sally A.
    Ryan, Brent J.
    Faergeman, Nils J.
    Hyttel, Poul
    Meyer, Morten
    STEM CELL REPORTS, 2021, 16 (06): : 1510 - 1526
  • [7] PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
    Duan, Huijie
    Lei, Zhong
    Xu, Fei
    Pan, Tao
    Lu, Demin
    Ding, Peili
    Zhu, Chunpeng
    Pan, Chi
    Zhang, Suzhan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] ADHD-associated PARK2 copy number variants: A pilot study on gene expression and effects of supplementary deprivation in patient-derived cell lines
    Radtke, Franziska
    Palladino, Viola Stella
    McNeill, Rhiannon V.
    Chiocchetti, Andreas G.
    Haslinger, Denise
    Leyh, Matthias
    Gersic, Danijel
    Frank, Markus
    Gruenewald, Lena
    Klebe, Stephan
    Bruestle, Oliver
    Guenther, Katharina
    Edenhofer, Frank
    Kranz, Thorsten M.
    Reif, Andreas
    Kittel-Schneider, Sarah
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2022, 189 (7-8) : 257 - 270
  • [9] Energy metabolism disturbance, altered neuronal development and glutamatergic signalling in human derived neuronal cell models of ADHD
    Kittel-Schneider, S. D.
    McNeill Kittel-Schneider, A. G.
    EUROPEAN PSYCHIATRY, 2024, 67 : S22 - S22
  • [10] DOWN-REGULATION OF PARK2 AND PACRG IN CLEAR CELL RENAL CELL CARCINOMA IS ASSOCIATED WITH TUMOUR AGGRESSIVENESS
    Wuttig, D.
    Toma, M. I.
    Kaiser, S.
    Fuessel, S.
    Weber, T.
    Grimm, M. O.
    Baretton, G.
    Wirth, M. P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 193 - 193